TrialAnnals of hematology2024

Development of a target concentration intervention to individualize paroxysmal nocturnal hemoglobinuria treatment with pegcetacoplan.

Mendy Ter Avest et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.